SEC Comment Letter 0000000000-25-001385 to MESOBLAST LTD (MESO, MEOBF) (CIK 0001345099) (MESO)
MESOBLAST LTD (MESO, MEOBF) (CIK 0001345099)
Date: Feb. 7, 2025 · CIK: 0001345099 · Accession: 0000000000-25-001385
AI Filing Summary & Sentiment
File numbers found in text: 333-284705
Letter
February 7, 2025 Silviu Itescu Managing Director and Chief Executive Officer Mesoblast Limited Level 38, 55 Collins Street Melbourne, VIC 3000, Australia Re:Mesoblast Limited Registration Statement on Form F-3 Filed February 5, 2025 Amendment No. 1 to Registration Statement on Form F-3 Filed February 6, 2025 File No. 333-284705 Dear Silviu Itescu: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Andrew Reilly
Show Raw Text
February 7, 2025
Silviu Itescu
Managing Director and Chief Executive Officer
Mesoblast Limited
Level 38, 55 Collins Street
Melbourne, VIC 3000, Australia
Re:Mesoblast Limited
Registration Statement on Form F-3
Filed February 5, 2025
Amendment No. 1 to Registration Statement on Form F-3
Filed February 6, 2025
File No. 333-284705
Dear Silviu Itescu:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Andrew Reilly